Filing Flows › Inovio Pharmaceuticals (INO) › Stock forecast & fair value
Inovio Pharmaceuticals (INO) stock forecast and price target
Inovio Pharmaceuticals (INO) trades at $1.22. 3 analysts' median price target is $5.00 (+312%), from $3.00 to $8.00.
Inovio Pharmaceuticals' latest quarter
Inovio Pharmaceuticals, Q1 2025: revenue $65K, net loss $19.7M, operating cash flow −$26.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for INO stock?
The median of 3 analysts' 12-month targets is $5.00, +312% from $1.22; the range is $3.00 to $8.00. The average rating is strong buy.
Does Inovio Pharmaceuticals usually beat earnings estimates?
It beat the consensus EPS estimate in 75% of the quarters on record.
Is INO stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.